TickerFactsScreenerDevelopers

Protagonist Therapeutics, Inc (PTGX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2013: $8.46M2014: $9.32M2015: $4.05M2016: $21.08M2017: $106.03M2018: $82.23M2019: $33.01M2020: $117.36M2021: $123.67M2022: $125.74M2023: $186.73M2024: $97.25M2025: $128.39M$128.39M
2013Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$128.39M+32.0%
2024$97.25M-47.9%
2023$186.73M+48.5%
2022$125.74M+1.7%
2021$123.67M+5.4%
2020$117.36M+255.6%
2019$33.01M-59.9%
2018$82.23M-22.4%
2017$106.03M+402.9%
2016$21.08M+420.0%
2015$4.05M-56.5%
2014$9.32M+10.2%
2013$8.46M—